13,232 results on '"MOTOR NEURON DISEASE"'
Search Results
2. AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis (LUMINA)
3. A Prospective Study to Evaluate the Correlation Between Oculometric Measurements and Clinical Endpoints in ALS Patients
4. Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Prospective Cohort Study
5. Effects of Long Term Ventilation Support on the Quality of Life of ALS Patients and Their Families (ALS-LTMV)
6. Exploring Nasal Drop Therapy With Small Extracellular Vesicles for ALS (de-ALS)
7. Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen in Norway: A Validation Study
8. A Safety and Efficacy Study of ARGX-119 in Adult Patients with Amyotrophic Lateral Sclerosis (ALS) (ReALiSe)
9. ALS Phase II Study of NX210c (SEALS)
10. Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
11. RolloverTreatment with Triumeq for People with ALS Following the Lighthouse II Trial (Lighthouse III)
12. Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis
13. Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing
14. A Study Evaluating the Safety and Tolerability of QRL-201 in ALS
15. RAPA-501 Therapy for ALS Expanded Access Protocol
16. Virtual Peer-to-peer Support Programme for Carers of MND
17. A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS) (ASTRALS)
18. Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study (CALM)
19. Evaluation of MN-166 (ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients with ALS (COMBAT-ALS)
20. Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD
21. An IIT Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Injection of SNUG01 in Patients with Amyotrophic Lateral Sclerosis (ALS)
22. An Open Label Extension Study of Monepantel in Individuals With Motor Neurone Disease
23. ASSESS ALL ALS Study
24. Dysphagia, QoL and Attitudes Towards PEG in ALS Patients (ALSDPEG)
25. Spastic Paraplegia - Centers of Excellence Research Network (SP-CERN)
26. Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS (ALCALS)
27. Contralateral R1 in Amyotrophic Lateral Sclerosis (MOTOBLINK)
28. Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS)
29. Triumeq in Amyotrophic Lateral Sclerosis (LIGHTHOUSE II)
30. EIM Via the Myolex mScan as an ALS Biomarker (ElectricALS)
31. Study of [11C]CPPC to Assess the Safety and Tolerability in Patients With ALS
32. Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients With ALS (ALSummit)
33. Remote Speech and Swallowing Assessment in ALS
34. Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket Trial (NADALS)
35. The NO-ALS Study: a Trial of Nicotinamide/pterostilbene Supplement in ALS.
36. Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS (CARDINALS)
37. Biomarkers in Different Types of Amyotrophic Lateral Sclerosis (ALS) Patients Being Treated With Edaravone
38. Study of SPG302 in Healthy Volunteers and ALS Participants
39. Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation
40. Use of Dalfampridine in Primary Lateral Sclerosis
41. Development and Test of a Headset for BCI Until Obtaining an Efficient and Comfortable System That Can be Used in Daily Practice by ALS People (TECH-ICOPA)
42. Mechanical Insufflation in the Philadelphia Amyotrophic Lateral Sclerosis Cohort (MI-PALS) Study (MI-PALS)
43. Oral Intake of Enteral Nutrition Formula Preceding Placement and Feeding Via GTube and Its Impact on Formula Intolerance in PALS
44. Retrospective Study on the Safety and Therapeutic/Improvement Effects of Intravenous Administration of SHED-CM for ALS (SHED-CAH2023)
45. Influence of Olfacto-gustatory Sensoriality on the Nutritional Status of Patients with Amyotrophic Lateral Sclerosis (GOUSLA)
46. Study of Inherited Neurological Disorders
47. A Biomarker Study to Evaluate MN-166 in Subjects With Amyotrophic Literal Sclerosis (ALS)
48. Development and Validation of the FBIndex to Determine the Risk of Falls for Patients with Neuromuscular Disorders (FBIndex)
49. Digital App for Speech & Health Monitoring
50. PREVENT ALL ALS Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.